摘要
目的评价宫颈癌筛查中,液基薄层技术(Thin-Cytologic Test,TCT)的应用价值。方法在2013年2月-2018年2月期间,对21 855例患者予以宫颈TCT检查,TCT阳性在阴道镜下予以宫颈活检病理检查。记录满意度、感染率、发炎率。结果 21 855例TCT检查中,满意为19 935例(91.21%),基本满意1 500例(6.86%),不满意420例(1.93%),总满意度98.07%;21 855例中,TCT阳性1 410例(6.45%),其中ASCUS 855例(60.63%),ASC-H 30例(2.13%),LSIL 330例(23.40%),HISL 165例(11.70%),AGC-US 30例(4.31%);21 855例标本中,感染18 150例,感染率83.05%,其中轻度发炎10 230例(46.80%),中度发炎4 260例(19.49%),重度发炎3 030例(13.86%),滴虫15例(0.08%),念珠菌75例(0.34%),细菌过度增殖675例(1.85%),疱疹15例(0.08%),HPV 120例(0.55%)。结论宫颈癌早期筛查中,TCT的有效性显著,更进一步降低了宫颈癌发生率,提升女性生活质量,保护女性生命安全,这对于临床研究具有重要作用。
Objective To evaluate the application value of thin-Cytologic Test(TCT) in cervical cancer screening. Methods Between February 2013 and February 2018, 21 855 patients were examined with cervical TCT. TCT-positive patients were examined with colposcopy for cervical biopsy. Record satisfaction, infection rate, and inflammation rate. Results Among the21 855 cases of TCT examination, the satisfaction rate was 19 935 cases(91.21%), the basic satisfaction rate was 1 500 cases(6.86%), the dissatisfaction rate was 420 cases(1.93%), and the total satisfaction rate was 98.07%, 1 410 cases of TCT check positive(6.45%), of which 855 were ASCUS(60.63%), 30 were ASC-H(2.13%), 330 were LSIL(23.40%), 165 were HISL(11.70%), 30 were AGC-US(4.31%);Among the specimens, 18,150 cases were infected, and the infection rate was 83.05%. Among them, 10 230 cases were mild inflammation(46.80%), 4 260 cases were moderate inflammation(19.49%), 3 030 cases were severe inflammation(13.86%), and 15 cases(0.08%), 75 cases of Candida(0.34%), 675 cases of hyperproliferation(1.85%), 15 cases of herpes(0.08%), 120 cases of HPV(0.55%). Conclusion The effectiveness of TCT in early screening of cervical cancer significantly, it has further reduced the incidence of cervical cancer, improved the quality of life of women, and protected the safety of women’s lives, which has an important role in clinical research.
作者
孙涛
周喆焱
徐开军
沈娅俊
周虹
SUN Tao;ZHOU Zhe-yan;XU Kai-jun;SHEN Ya-jun;ZHOU Hong(Department of Pathology,the Third People's Hospital of Yunnan Province,Kunming,Yunnan Province,650011 China;Department of Pathology,the Second People's Hospital of Yunnan Province,Kunming,Yunnan Province,650021 China)
出处
《中外医疗》
2020年第8期23-25,共3页
China & Foreign Medical Treatment
关键词
TCT技术
宫颈癌
筛查
价值分析
TCT technology
Cervical cancer
Screening
Value analysis
作者简介
孙涛(1968-),女,云南通海人,本科,副主任医师。主要从事病理科诊断工作;通讯作者:周虹(1964-),女,云南曲靖人,本科,主任医师,主要从事病理科诊断及教学工作,E-mail:925690630@qq.com。
